Tau monoclonal antibody generation based on humanized yeast models: Impact on tau oligomerization and diagnostics

  • Joëlle Rosseels
  • , Jeff Van Den Brande
  • , Marie Violet
  • , Dirk Jacobs
  • , Pierre Grognet
  • , Juan Lopez
  • , Isabelle Huvent
  • , Marina Caldara
  • , Erwin Swinnen
  • , Anthony Papegaey
  • , Raphaëlle Caillierez
  • , Valerie Buée-Scherrer
  • , Sebastiaan Engelborghs
  • , Guy Lippens
  • , Morvane Colin
  • , Luc Buée
  • , Marie Christine Galas
  • , Eugeen Vanmechelen
  • , Joris Winderickx

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Background: Oligomers of protein Tau are associated with neurodegenerative diseases. Results: New antibodies were generated and validated that recognize different degrees of oligomerization of protein Tau. Conclusion: Low order and higher order oligomers differ in C-terminal Tau phosphorylation and reflect consecutive stages in disease progression. Significance: Antibodies recognizing Tau oligomers provide insight into disease etiology and are promising diagnostic tools.

Original languageEnglish
Pages (from-to)4059-4074
Number of pages16
JournalJournal of Biological Chemistry
Volume290
Issue number7
DOIs
StatePublished - 13 Feb 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Tau monoclonal antibody generation based on humanized yeast models: Impact on tau oligomerization and diagnostics'. Together they form a unique fingerprint.

Cite this